he fight over the cost of medicines has erupted in yet another country as members of the Chilean congress have asked the government to sidestep patents on several treatments in hopes of widening access for their citizens.

In a petition delivered on Monday, the representatives and several patient advocacy groups asked Chilean health minister Carmen Castillo Taucher to issue compulsory licenses for the Xtandi prostate cancer therapy and several hepatitis C medicines sold by Gilead Sciences.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.